tradingkey.logo

STRATA Skin Sciences Inc

SSKN

1.940USD

-0.010-0.51%
Market hours ETQuotes delayed by 15 min
8.09MMarket Cap
LossP/E TTM

STRATA Skin Sciences Inc

1.940

-0.010-0.51%
More Details of STRATA Skin Sciences Inc Company
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Company Info
Ticker SymbolSSKN
Company nameStrata Skin Sciences Inc
IPO dateOct 28, 2005
CEODr. Dolev Rafaeli
Number of employees106
Security typeOrdinary Share
Fiscal year-endOct 28
Address5 Walnut Grove Drive, Suite 140
CityHORSHAM
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code19044
Phone12156193200
Websitehttps://www.strataskinsciences.com/
Ticker SymbolSSKN
IPO dateOct 28, 2005
CEODr. Dolev Rafaeli
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
+334.33%
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
+334.33%
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States (Country)
4.40M
64.55%
China
834.00K
12.24%
Middle East
711.00K
10.44%
Foreign
479.00K
7.03%
Other foreign
391.00K
5.74%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 9
Updated: Fri, May 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
34.57%
22NW, LP
12.87%
Nantahala Capital Management, LLC
9.68%
Rafaeli (Dolev)
3.43%
Renaissance Technologies LLC
2.44%
Other
37.00%
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
34.57%
22NW, LP
12.87%
Nantahala Capital Management, LLC
9.68%
Rafaeli (Dolev)
3.43%
Renaissance Technologies LLC
2.44%
Other
37.00%
Shareholder Types
Shareholders
Proportion
Private Equity
34.57%
Investment Advisor/Hedge Fund
13.56%
Hedge Fund
12.86%
Individual Investor
3.91%
Investment Advisor
3.10%
Other
32.01%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
42
2.84M
68.02%
+23.70K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
2023Q1
52
2.47M
70.89%
-108.51K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Accelmed Growth Partners Management Ltd
1.44M
34.57%
--
--
Mar 31, 2025
22NW, LP
537.00K
12.87%
--
--
Mar 31, 2025
Nantahala Capital Management, LLC
403.92K
9.68%
--
--
Mar 31, 2025
Rafaeli (Dolev)
143.16K
3.43%
+110.20K
+334.33%
Mar 31, 2025
Renaissance Technologies LLC
101.83K
2.44%
-1.50K
-1.45%
Mar 31, 2025
The Vanguard Group, Inc.
84.63K
2.03%
+316.00
+0.37%
Mar 31, 2025
Citadel Advisors LLC
28.84K
0.69%
-2.38K
-7.63%
Mar 31, 2025
Rubinstein (Samuel)
19.86K
0.48%
+18.03K
+983.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
18.27K
0.44%
+1.41K
+8.34%
Mar 31, 2025
MGO One Seven LLC
17.14K
0.41%
+17.14K
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Date
Type
Ratio
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
KeyAI